Volume 187, Issue 4, Oct 2022

EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Osteoporosis management

• Abstract
• View article

Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma

• Abstract
• View article

The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes

• Abstract
• View article
• Supplementary data

Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics

• Abstract
• View article
• Supplementary data

Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension

• Abstract
• View article
• Supplementary data

Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study

• Abstract
• View article
• Supplementary data

Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients

• Abstract
• View article
• Supplementary data

Risk factors associated with mortality among individuals with type 2 diabetes and depression across two cohorts

• Abstract
• View article
• Supplementary data

Acrolein plays a culprit role in the pathogenesis of diabetic nephropathy in vitro and in vivo

• Abstract
• View article
• Supplementary data

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

• Abstract
• View article
• Supplementary data

Erratum to: “Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation”

• Extract
• View article